EPA vs DHA

EPA and DHA are both marine omega-3 fatty acids, but treating them as interchangeable is a mistake the clinical trial record has made expensive.

What the cardiovascular trials show

REDUCE-IT tested icosapent ethyl, a purified EPA-only formulation, at 4 g per day and found a roughly 25% reduction in major adverse cardiovascular events (MACE) [1]. STRENGTH tested a 4 g mixture of EPA plus DHA and found no benefit [2]. The gap between those two outcomes remains unexplained. One possibility is that EPA carries the cardioprotective signal and DHA dilutes it. Another, taken seriously by researchers, is that the trials used different placebos: REDUCE-IT used mineral oil, STRENGTH used corn oil, and the placebo choice may have distorted the comparison. Verhoeven's analysis suggests EPA is "the type considered the focus of heart health," though the full picture remains unresolved [3].

DHA plays a different role

DHA is the structurally dominant omega-3 in brain tissue, and it is the form more closely tied to emerging signals around cancer biology and immunotherapy response [4, 5]. For brain structure and development, DHA matters more than EPA. For the inflammatory component of depression, the evidence points the other way. EPA-rich products have consistently outperformed DHA-rich products in depression randomized controlled trials. Harris's mechanistic explanation is that EPA exerts anti-inflammatory effects in brain circulation without entering membrane structures the way DHA does. That makes EPA more relevant to the inflammatory pathway implicated in depression [6, 7]. The mechanistic reasoning is expert opinion, though the clinical pattern across RCTs supports it.

Why you cannot substitute one for the other

A critical pharmacological point lost in general omega-3 marketing: DHA does not retro-convert to EPA in the body, and EPA does not raise DHA levels either. Harris notes that supplementing DHA leaves RBC EPA unchanged, and supplementing EPA leaves RBC DHA unchanged or slightly lower [6, 7]. If both are targets, both must be provided.

Plant-based ALA (found in flaxseed, walnuts, chia) is not a reliable substitute for marine EPA or DHA. A dose of 12 g of ALA raises RBC EPA from roughly 1% to 2%, a modest and clinically insufficient change [8]. There is a meaningful sex difference: women, driven by estrogen, convert ALA to DHA at substantially higher rates than men, who preferentially burn ALA for energy [8].

Formulation affects how much you absorb

Triglyceride-form omega-3s are better absorbed than ethyl ester (EE) forms, particularly when taken with a meal [9, 10]. EPA in ethyl ester form has shown bleeding risk in subgroup analyses; the triglyceride form has not shown the same signal [9, 10]. The Omega-3 Index measures combined EPA plus DHA in red blood cell membranes and is the standard way to assess tissue status. The formulation you use, and whether you take it with fat, will affect whether your index moves.

Where the evidence is contested

The central unresolved question is whether the difference between REDUCE-IT and STRENGTH reflects a genuine biological distinction between EPA and DHA, or whether it reflects the placebo design [1, 2]. Mineral oil, used in REDUCE-IT, may have raised LDL and inflammation in the control arm, artificially inflating the apparent benefit of icosapent ethyl. Corn oil, used in STRENGTH, may have had small anti-inflammatory effects that compressed the treatment difference. Neither interpretation has been ruled out. Until a large trial tests EPA-only against a metabolically inert placebo without lipid effects, the EPA-specific cardiovascular benefit claim rests on one positive trial whose placebo remains under dispute. Readers evaluating cardiovascular omega-3 supplementation should weigh both outcomes rather than treating REDUCE-IT as the settled answer.

References

1. REDUCE-IT (Bhatt 2019, NEJM) — EPA 4g, MACE ↓25% · PubMed 30415628
2. STRENGTH (Nicholls 2020, JAMA) — EPA+DHA 4g null · PubMed 33190147
3. Analyst/expert source (S040) — see our methodology
4. raw/physionic/omega3-fishoil/02-omega3-supercharges-cancer-immunity.txt
5. raw/physionic/omega3-fishoil/11-your-brain-on-fish-oil-many-studies.txt
6. Attia #83 — Bill Harris: omega-3 fatty acids
7. raw/foundmyfitness/fmf-harris-omega3-index.txt
8. Analyst/expert source (S048) — see our methodology
9. Analyst/expert source (S042) — see our methodology
10. Analyst/expert source (S045) — see our methodology